What non-invasive glucose monitors are and why they matter

A non-invasive glucose monitor measures your blood sugar without pricking your finger or inserting a sensor under your skin. Instead, these devices read glucose through your skin using light, electromagnetic waves, or other methods that don't break the surface. The appeal is obvious: no pain, no fingerstick blood, no insertion procedure.

The reality is more complicated. Most non-invasive devices that exist today are still in research or early testing. The ones already on the market work differently than traditional monitors and come with real limitations. If you have diabetes and are considering one, you need to know what's actually available now, what it can and cannot do, and what researchers are still trying to solve.

Key Takeaways

  • The only non-invasive glucose monitor currently sold in the United States is the GlucoTrack, which uses ultrasound and electromagnetic waves and requires a prescription.
  • Most other non-invasive devices in development—including optical and transdermal monitors—have not yet been cleared by the FDA for routine diabetes management.
  • Non-invasive monitors typically measure interstitial fluid glucose, not blood glucose directly, which means they lag behind your actual blood sugar by 5 to 15 minutes.
  • Continuous glucose monitors (CGMs) that use a small inserted sensor are minimally invasive and far more accurate than current non-invasive options, making them the standard for people who want frequent readings without fingersticks.
  • Researchers are working on optical, transdermal, and wearable non-invasive monitors, but significant technical hurdles remain before any reach widespread use.

The only non-invasive option available now: GlucoTrack

The GlucoTrack, made by Integrity Applications, is the only non-invasive glucose monitor cleared by the FDA for use in the United States. It was approved in 2016. The device clips onto your earlobe and uses three technologies at once—ultrasound, electromagnetic waves, and thermal (heat) sensing—to estimate glucose levels in interstitial fluid, the liquid surrounding your cells.

You need a prescription to buy one. The device requires calibration with fingerstick blood glucose readings, meaning you still have to prick your finger several times to teach it your patterns. After calibration, it can give readings without fingersticks, but accuracy varies. Studies show it works reasonably well for some people and less reliably for others, depending on individual factors like skin thickness and blood flow.

GlucoTrack is not widely used in the United States. It is more common in Europe and other regions. Insurance coverage is inconsistent, and the device is expensive. Many people with diabetes find that continuous glucose monitors (CGMs)—which use a tiny inserted sensor—offer better accuracy and are easier to obtain through insurance.

Why most non-invasive monitors are still not ready for daily use

Dozens of non-invasive glucose monitoring technologies are in development around the world. They use different approaches: some shine light through your skin and measure how glucose absorbs it, others use radio waves, and still others measure glucose in sweat or tears. Despite decades of research, none of these have reached the accuracy and reliability needed for routine diabetes management.

The core problem is that glucose levels in blood change quickly—sometimes within minutes—but glucose in interstitial fluid (the fluid between cells) lags behind by 5 to 15 minutes. Non-invasive devices cannot measure blood glucose directly; they measure glucose in other body fluids or tissues. This delay matters enormously if you are trying to prevent low blood sugar or adjust insulin doses in real time. A reading that is 10 minutes old can be dangerously outdated during exercise or after a meal.

A second problem is accuracy. The FDA requires glucose monitors to meet strict accuracy standards. Most non-invasive prototypes drift over time, give inconsistent readings in different people, or fail in certain conditions like high humidity or low skin temperature. Optical monitors, for example, struggle because skin color, hair, and tattoos all affect how light passes through tissue.

A third barrier is the need for calibration. Even GlucoTrack requires fingerstick calibrations. If a non-invasive monitor needs frequent calibrations, it loses much of its appeal over traditional fingerstick testing or over CGMs, which need only occasional calibrations.

How continuous glucose monitors compare to non-invasive options

Continuous glucose monitors (CGMs) are often called "minimally invasive" rather than non-invasive because they do require a small sensor inserted under your skin. Common CGMs include the Freestyle Libre, Dexcom G6, and Medtronic Guardian. You wear the sensor for 7 to 14 days, then replace it. A transmitter sends readings to your phone or receiver every few minutes.

CGMs are far more accurate than current non-invasive monitors. They measure interstitial glucose continuously and have been refined over years to account for the lag time. Most people find them reliable enough to make insulin dosing decisions. They are also covered by most insurance plans when prescribed by a doctor, making them more accessible than GlucoTrack.

The trade-off is that CGMs do require insertion. The needle is small and the insertion is quick, but it is still a procedure. Some people find the adhesive patch uncomfortable or develop skin irritation. For many people with diabetes, however, the accuracy and convenience of a CGM outweigh the minor discomfort of insertion.

What researchers are developing right now

Several promising non-invasive technologies are in clinical trials or late-stage development. Optical glucose monitors use near-infrared light to measure glucose in tissue. Companies like Medtronic and others have tested these, but they still struggle with accuracy and consistency across different skin types. Transdermal monitors attempt to measure glucose in sweat or through the skin barrier using tiny electrical currents. Raman spectroscopy, which uses laser light to identify glucose molecules, shows potential but requires expensive equipment.

Wearable patches that measure glucose in interstitial fluid without insertion are also in development. Some use microneedles so small they do not cause pain, though they still technically pierce the skin. Others use ultrasound or electromagnetic waves similar to GlucoTrack but in a smaller, more convenient form.

The timeline for these devices is uncertain. A technology that works in the lab may take 5 to 10 years to reach FDA approval, and approval does not may provide it will be accurate enough for routine use or that insurance will cover it. Researchers are realistic about the challenges: non-invasive glucose monitoring remains one of the hardest problems in medical device development.

What to consider if you are looking for a glucose monitor now

If you have diabetes and want frequent glucose readings without fingersticks, a continuous glucose monitor is your most practical option today. CGMs are accurate, widely available, and covered by most insurance. Talk to your doctor about which CGM system might work best for your lifestyle and insurance plan.

If you are specifically interested in a truly non-invasive option, GlucoTrack is available by prescription, but you should discuss its limitations with your doctor. It requires calibration, may not work equally well for everyone, and is expensive. Your doctor can help you decide whether it is worth trying based on your individual situation.

If you are waiting for a breakthrough non-invasive monitor, stay informed through your diabetes care team or organizations like the American Diabetes Association. New devices do move through development, but the timeline is long and not every prototype becomes a product.

The gap between what we want and what technology can deliver

Non-invasive glucose monitoring represents a genuine unmet need. People with diabetes would prefer not to have any device inserted under their skin, and researchers have been working toward that goal for decades. The challenge is not lack of effort or funding—it is that the human body is complex, glucose sensing is technically difficult, and the accuracy required for safe diabetes management is very high.

The devices that do exist today, like GlucoTrack and the many CGMs on the market, represent real progress. They have freed millions of people from constant fingerstick testing. A truly non-invasive monitor that matches the accuracy of current CGMs would be a significant advance, but it is not yet here. Understanding what is available now and what is still in development helps you make informed decisions about your own glucose monitoring.

Frequently Asked Questions

Can I use my smartwatch or fitness tracker to monitor glucose?

Most smartwatches and fitness trackers cannot measure glucose at all. Some newer devices are being tested for this purpose, but none are currently approved by the FDA for glucose monitoring. If you see a wearable claiming to measure glucose, check whether it has FDA clearance before relying on it for diabetes management.

Is GlucoTrack covered by insurance?

Coverage varies by insurance plan and state. Some plans cover it with a prescription, while others do not. Contact your insurance company directly to ask about coverage. You will also need a prescription from your doctor, and they can help you navigate the coverage process.

Why can't non-invasive monitors measure blood glucose directly instead of interstitial fluid?

Blood is inside your veins and arteries, deep under the skin. Non-invasive methods like light or radio waves cannot reliably reach blood glucose without also measuring glucose in surrounding tissues. A sensor inserted under the skin can sit in interstitial fluid and measure it continuously, which is why CGMs work better than current non-invasive options.

How soon will a non-invasive glucose monitor be available?

There is no set timeline. Several devices are in development, but moving from clinical trials to FDA approval typically takes years. Even after approval, a device must prove it is accurate and reliable enough for doctors to recommend it. It is possible a new non-invasive monitor could reach the market in the next 5 to 10 years, but this is not certain.

If I use a CGM, am I still considered to have an invasive device?

CGMs are called minimally invasive because the sensor is small and inserted just under the skin for a short time. The insertion is quick and the needle is tiny. Many people do not consider this a significant barrier compared to fingerstick testing multiple times a day, but it is still a procedure. If you want to avoid any skin insertion, a truly non-invasive monitor like GlucoTrack is your only current option.